» » Mechanisms of Ibrutinib Resistance Identified in the Treatment of Chronic Lymphocytic Leukemia

Mechanisms of Ibrutinib Resistance Identified in the Treatment of Chronic Lymphocytic Leukemia

A new study shows how resistance develops in patients taking ibrutinib, a new and highly effective drug for the treatment of chronic lymphocytic leukemia (CLL). The study was published in the emNew England Journal of Medicine/em and led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James). It identifies gene mutations that cause ibrutinib resistance ...

Read More
You have just read an article categorized health titled Mechanisms of Ibrutinib Resistance Identified in the Treatment of Chronic Lymphocytic Leukemia.
Written by: editor - Monday, June 2, 2014

There are currently no comments for "Mechanisms of Ibrutinib Resistance Identified in the Treatment of Chronic Lymphocytic Leukemia"

Post a Comment

Subscribe to: Post Comments (Atom)